Cited by 49Rheumatoid Arthritis Research and TherapiesImmune Response and InflammationImmunotherapy and Immune Responses

The mechanisms of hydroxychloroquine in rheumatoid arthritis treatment: inhibition of dendritic cell functions via Toll like receptor 9 signaling

Open access
Han, Jiaochan, Li, Xing, Luo, Xiaoqing, He, Juan, Huang, Xuechan, Zhou, Qingyou, Han, Yanping, Jie, Hongyu +8 more·2020·Biomedicine & Pharmacotherapy

Abstract

Hydroxychloroquine (HCQ) is one of the most commonly prescribed immune-suppressants in treating rheumatoid arthritis (RA). Our previous research showed that HCQ suppressed RA development by inhibiting T follicular helper (Tfh) cells directly. Dendritic cells (DCs) serve as the link between innate and acquired immunity. Whether HCQ suppressed Tfh cell through DCs was not clear. In current study, we found that HCQ efficiently inhibited CD86, chemokine (C-X-C motif) receptor 4 (CXCR4) expression and interferon-α (IFN-α) secretion of healthy donor derived purified DCs stimulated by RA patient serum. To mimic RA, collagen-induced arthritis (CIA) mouse model was used and treated with HCQ daily for fifty-four days prior to sacrifice. We found HCQ inhibited DC maturation and migration to lymph nodes (LNs), manifested as down-regulated expression of CD40, CD80, CD86, MHCII (I-Aq) on LN DCs. In addition, HCQ reduced the level of chemokine receptor 7 (CCR7) and L-selectin on peripheral blood DCs and diminished percentage of LN DCs. Of note, HCQ only inhibited CpG ODN 1826-induced IL-12 secretion by bone marrow DCs (BMDCs) stimulated by various toll like receptor (TLR) agonists. Mechanistically, HCQ down-regulated the expression of TLR9 not only in healthy donor PBMC-derived DCs stimulated by RA patient serum, but also in LN DCs of CIA mice and CpG-activated BMDCs. Furthermore, arthritis scores in TLR9−/− mice were much lower than that in wild type mice with impaired maturity and migration capability of DCs. Collectively, activation of DCs contributes to the pathogenesis of RA and HCQ shows protective effects on RA by inhibition of DC activation via blocking TLR9.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.biopha.2020.110848

Cites

45 of 45 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Hydroxychloroquine has been purported to interact with and antagonise the key intracellular nucleic acid sensors TLR9 and cGAS, which likely contribute to its clinical efficacy in rheumatoid arthritis and systemic lupus erythematosus.

    “Hydroxychloroquine has been purported to interact with and antagonise the key intracellular nucleic acid sensors, TLR9 and cGAS, which likely contribute to its clinical efficacy in rheumatoid arthritis and systemic lupus erythematous (Han et al., 2020).”

    From Gene Therapy-Associated Uveitis (GTAU): Understanding and mitigating the adverse immune response in retinal gene therapy (2025) · cites this paper as Han et al., 2020

    The Discussion supports hydroxychloroquine blocking TLR9 in rheumatoid arthritis, but explicitly says it 'could only' block TLR9 and proposes combining it with a separate cGAS inhibitor. That contradicts the claim that this paper attributes cGAS antagonism to hydroxychloroquine. The cited passages do not establish this mechanism as contributing to its clinical efficacy in systemic lupus erythematosus; page numbers are unavailable in our copy. (LLM, conf=0.88)

    Checked by a reasoning model — may be wrong.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

1 of the 46 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Han, J., Li, X., Luo, X., He, J., Huang, X., Zhou, Q., Han, Y., Jie, H., Zhuang, J., Li, Y., Yang, F., Zhai, Z., Wu, S., He, Y., Yang, B., & Sun, E.
Affiliations
  • Third Affiliated Hospital of Southern Medical University (CN)
  • Peking University Shenzhen Hospital (CN)
  • Guangdong Provincial People's Hospital (CN)
  • Southern Medical University (CN)
  • South China Normal University (CN)
Corresponding author
  • He, Yi
  • Yang, Bin
  • Sun, Erwei
Venue
Biomedicine & Pharmacotherapy
Publisher
Elsevier BV
Published
2020-12
Volume
132
Pages
110848
ISSN
0753-3322 (ISSN-L)
OpenAlex
W3092456362
Cited by
49
References
46
Citations by year
2026: 1 · 2025: 9 · 2024: 12 · 2023: 11 · 2022: 7 · 2021: 9
FWCI
5.09
Type
journal article
Language
en
Open access
Locations
  • Biomedicine & Pharmacotherapy (publishedVersion, cc-by-nc-nd)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
National Natural Science Foundation of China
Topics
  • Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
  • Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
  • Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
Keywords
hydroxychloroquine, rheumatoid arthritis, dendritic cells, TLR9, T follicular helper cells, dendritic cell maturation, dendritic cell migration, interferon-alpha, CXCR4, CCR7, L-selectin, IL-12, collagen-induced arthritis, TLR9-deficient mice, immunosuppression
MeSH terms
Adult, Aged, Animals, Arthritis, Experimental, Arthritis, Rheumatoid, Dendritic Cells, Female, Humans, Hydroxychloroquine, Male, Mice, Inbred C57BL, Mice, Inbred DBA, Middle Aged, Signal Transduction, Down-Regulation, Case-Control Studies, Mice, Knockout, Antirheumatic Agents, Toll-Like Receptor 9, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review